Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H19N5O2S |
InChIKeyKOCVKGYKBLJEPK-UHFFFAOYSA-N |
CAS Registry331244-89-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 27 May 2012 |